Supplementation with nicotinamide limits accelerated aging in affected individuals with cockayne syndrome and restores antioxidant defenses
Figure 5.P62 and PINK1 expression in CS-A, CS-B, and elderly affected individuals’ fibroblast normalized to non-treated control conditions of each group under doses of 1mg/ml NAM (N=1 for CS groups done in duplicate).